Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
Eli Lilly
(NY:
LLY
)
877.79
-31.53 (-3.47%)
Official Closing Price
Updated: 7:00 PM EDT, Sep 27, 2024
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
All News about Eli Lilly
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
Unpacking the Latest Options Trading Trends in Eli Lilly and Co
May 02, 2024
Via
Benzinga
3 Stocks Gunning for Trillion-Dollar Status: The Players to Own Now
May 02, 2024
These three stocks closing in on trillion-dollar valuations are ready to stand shoulder-to-shoulder with other industry giants.
Via
InvestorPlace
3 Staples Stocks to Cushion Lower Consumer Sentiment
May 02, 2024
Three stocks in the consumer staples sector could come to save investor portfolios from potential underperformance following sentiment contractions
Via
MarketBeat
Topics
Economy
Exposures
Economy
Demand Soars For Novo Nordisk's Weight-Loss Drug Wegovy Despite Supply Constraints And Eli Lilly Competition
May 02, 2024
The Danish pharmaceutical company is now shipping more introductory doses of Wegovy to the U.S., as it grapples with supply constraints and competition from Eli Lilly.
Via
Benzinga
Here's Why Eli Lilly Stock Remains a Screaming Buy
May 02, 2024
The biggest healthcare company in the world could grow much larger over the next decade.
Via
The Motley Fool
What 23 Analyst Ratings Have To Say About Eli Lilly and Co
May 01, 2024
Via
Benzinga
Why Eli Lilly Stock Is Jumping Today
April 30, 2024
Investors are cheering the big-pharma company's improved outlook.
Via
The Motley Fool
Q1 Earnings Seasons Picks & Pans: The 4 Biggest Stock Winners (and 3 Losers)
May 01, 2024
Investors should take note of this earnings season winners and losers to see how stocks they own are doing now Q1 results have been released.
Via
InvestorPlace
Eli Lilly 'On Its Way' To $1 Trillion Market Cap, Analysts Say: It's A 'Have' In A Sea Of 'Have Nots'
May 01, 2024
Eli Lilly's first-quarter report shows a revenue surge of 26%, beating EPS expectations. Analysts maintain a bullish outlook.
Via
Benzinga
ETFs To Buy As Eli Lilly Beats Q1 Earnings, Lifts Outlook
May 01, 2024
Eli Lilly and Company posted mixed first-quarter 2024 earnings, beating earnings estimates but lagging on revenues. Investors seeking to tap the opportune moment could bet on ETFs having the largest...
Via
Talk Markets
Topics
ETFs
Profit from the Panic: 3 Stocks to Pounce on When They Become Steals
May 01, 2024
We love it when our favorite clothes go on sale, so when the market offers us a deal, these are the stocks to buy on dips.
Via
InvestorPlace
Stock Market Crash Warning: Don’t Get Caught Holding These 3 Consumer Stocks.
May 01, 2024
While some retail companies are still thriving, investors would be smart to steer clear of these consumer stocks to avoid.
Via
InvestorPlace
Stock Market Crash Alert: 3 Must-Buy Biotech Stocks When Prices Plunge
May 01, 2024
A slip in the market could give investors a rare opportunity to get some top biotech stocks to buy at a considerable discount.
Via
InvestorPlace
3 Healthcare Stocks With the Potential to Triple Your Investment by 2026
May 01, 2024
Learn how these three healthcare stocks offer sharp opportunities in pharmaceuticals, healthcare services, and biotechnology.
Via
InvestorPlace
Pfizer Embraces Direct-To-Consumer Model For Covid Antiviral, Says Comirnaty Revenues Continue To Perform Consistently With Expectations
May 01, 2024
Pfizer reports Q1 results: adjusted EPS beats estimates, driven by revenue growth. Significant declines in Comirnaty and Paxlovid revenues countered by operational gains. Company announces plans for...
Via
Benzinga
Exposures
COVID-19
Nearly 50% of Billionaire Stanley Druckenmiller's Portfolio Is Invested in These 4 Stocks
May 01, 2024
The billionaire's family fund is surprisingly concentrated.
Via
The Motley Fool
How Consumer Demand Is Impacting Taiwan Semiconductor Manufacturing Co.
May 01, 2024
We also look at the "treasure hunt" economy.
Via
The Motley Fool
These 3 Companies Recently Lifted Guidance
May 01, 2024
Several companies have raised their outlooks, with shares moving higher following the announcements. For those interested in recent bullish activity, let’s take a closer look at each.
Via
Talk Markets
Americans Swap $5 Burgers For $1,000 Weight Loss Drugs — Is Soda Getting Left Behind Too?
April 30, 2024
Weight-loss drugs may be impacting fast-food sales, as Eli Lilly beats estimates and raises revenue guidance while McDonald's and Coca-Cola report underwhelming quarters.
Via
Benzinga
Goldman Scrutinizes Hits, Misses, And Growth Trajectory Concerns For Eli Lilly And Its Its Obesity and Diabetes Drugs
April 30, 2024
Eli Lilly boosts production for obesity and diabetes drugs, reports mixed Q1 results. Expectations for supply growth in 2024 outlined. Insights into payor access and reimbursement strategies...
Via
Benzinga
Eli Lilly (LLY) Q1 2024 Earnings Call Transcript
April 30, 2024
LLY earnings call for the period ending March 31, 2024.
Via
The Motley Fool
Topics
Earnings
Exposures
Financial
10 Health Care Stocks With Whale Alerts In Today's Session
April 30, 2024
Via
Benzinga
Stocks Dive On Fears Of Hawkish Fed; Treasury Yields Rise, Bitcoin Tumbles To $60,000: What's Driving Markets Tuesday?
April 30, 2024
Investor apprehension grips Wall Street with major indices showing midday losses on Tuesday in New York trading, ahead of the Federal Reserve’s potentially hawkish pivot in Wednesday’s meeting.
Via
Benzinga
FOMC Meeting Samsung Over Takes Apple, AI Demand Indication Ahead From AMD, Amazon And Super Micro
April 30, 2024
To gain an edge, this is what you need to know today.
Via
Benzinga
Topics
Artificial Intelligence
Exposures
Artificial Intelligence
Why H&E Equipment Services Shares Are Trading Lower By Around 18%? Here Are Other Stocks Moving In Tuesday's Mid-Day Session
April 30, 2024
Via
Benzinga
Eli Lilly Increases FY24 Outlook, Joins Brinker International, Zebra Technologies, 3M And Other Big Stocks Moving Higher On Tuesday
April 30, 2024
Via
Benzinga
LLY Stock Earnings: Eli Lilly Beats EPS, Misses Revenue for Q1 2024
April 30, 2024
LLY stock results show that Eli Lilly beat analyst estimates for earnings per share but missed on revenue for the first quarter of 2024.
Via
InvestorPlace
Eli Lilly's Weight-Loss Drug Still Going Strong, Boosts Annual Forecast
April 30, 2024
"Eli Lilly & Co's Q1 2024: Revenue hits $8.8 billion, up 26% Y/Y, driven by volume & higher prices. Strong demand for key drugs like Mounjaro & Verzenio. EPS beats at $2.58. FY24 guidance raised to...
Via
Benzinga
Eli Lilly Stock Jumps On Strong Earnings, Guidance As Zepbound Sales Easily Beat
April 30, 2024
Overall revenue fell short in Q1. Lilly stock is set to cross a key level.
Via
Investor's Business Daily
Wall Street On Edge Ahead Of Fed Decision, Spotlight Falls On Amazon And AMD Earnings: Analyst Says Stocks Survive 'Fragility Test' As April Ends
April 30, 2024
U.S. stocks appear to be on the back foot early on Tuesday, with index futures trading modestly lower in early pre-market activity.
Via
Benzinga
Topics
Economy
Exposures
Interest Rates
< Previous
1
2
...
21
22
23
24
25
26
27
28
29
...
99
100
Next >
Data & News supplied by
www.cloudquote.io
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms and Conditions
.